Summary
IDEXX Laboratories, Inc. filed a Form 8-K on January 29, 2013, to announce its financial results for the fourth quarter and full year ended December 31, 2012. This filing primarily serves to furnish the press release containing these results as an exhibit, rather than to report a material event. Investors should refer to the press release (Exhibit 99.1) for detailed financial performance, including revenue, earnings, and any forward-looking guidance provided by the company for the upcoming periods.
Key Highlights
- 1IDEXX Laboratories announced its financial results for the fourth quarter and full year ended December 31, 2012.
- 2The announcement was made on January 29, 2013.
- 3The filing's primary purpose is to furnish a press release containing the financial results.
- 4The press release is included as Exhibit 99.1 to the Form 8-K.
- 5The information furnished is for the period ending December 31, 2012.
- 6The filing indicates that the information is furnished, not filed, under Item 2.02 of Form 8-K.
- 7The Chief Financial Officer, Merilee Raines, signed the report.
Frequently Asked Questions
The main purpose of this Form 8-K filing is to formally announce and provide access to IDEXX Laboratories' financial results for the fourth quarter and full year ended December 31, 2012, by furnishing the related press release as an exhibit.
The detailed financial results are provided in the press release, which is attached as Exhibit 99.1 to this Form 8-K filing.
According to the filing, the information furnished under Item 2.02 and its exhibit is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, meaning it does not carry the same legal liabilities as a formally filed report, unless specifically incorporated into other filings.
Merilee Raines, the Executive Vice President, Chief Financial Officer, and Treasurer, is the executive who signed this Form 8-K report on behalf of IDEXX Laboratories.